INTERNATIONAL PATENT: NIKANG THERAPEUTICS, INC. FILES APPLICATION FOR "BIFUNCTIONAL COMPOUNDS CONTAINING 2,5-SUBSTITUTED PYRIMIDINE DERIVATIVES FOR DEGRADING CYCLIN-DEPENDENT KINASE 2 AND CYCLIN-DEPENDENT KINASE 4 VIA UBIQUITIN PROTEASOME PATHWAY"

GENEVA, June 12 -- NIKANG THERAPEUTICS, INC. (200 Powder Mill Road, BLDG E500Wilmington, Delaware 19803) filed a patent application (PCT/US2024/057574) for "BIFUNCTIONAL COMPOUNDS CONTAINING 2,5-SUBSTITUTED PYRIMIDINE DERIVATIVES FOR DEGRADING CYCLIN-DEPENDENT KINASE 2 AND CYCLIN-DEPENDENT KINASE 4 VIA UBIQUITIN PROTEASOME PATHWAY" on Nov 26, 2024. With publication no. WO/2025/117616, the details related to the patent application was published on Jun 05, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): YU, Zhiyong (c/o NiKang Therapeutics, Inc.200 Powder Mill Road, BLDG E500Wilmington, Delawa...